Treatment of Neonatal Abstinence Syndrome

Completed · Phase 4

Conditions studied: Neonatal Abstinence Syndrome

In brief

This study compares treatment of Neonatal Abstinence Syndrome (NAS) with two different drugs for the difference in the length of treatment. This is a randomized, open-label comparison of phenobarbital and methadone versus phenobarbital and diluted deodorized tincture of opium (dDTO) where phenobarbital is the initial drug used to stabilize neonatal withdrawal.

Key facts

Study ID
NCT01723722
Run by
Eastern Maine Medical Center
People needed
40
Starts
2007-01-01
Expected to finish
2009-09-01
Last updated by the study team
2013-11-27

Who can join

Age: 0 and older, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.